L. Kodandapani

发表

First-in-class pan caspase inhibitor developed for the treatment of liver disease.

N. Chen, J. Díaz, K. Valentino, 2005, Journal of medicinal chemistry.

Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.

N. Chen, J. Díaz, A. Schmitz, 2005, Bioorganic & medicinal chemistry letters.

The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

M. Grütter, P. Mittl, S. D. Marco, 1999, Structure.

Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma Cells*

L. Fritz, K. Tomaselli, J. Krebs, 1998, The Journal of Biological Chemistry.

INTRAPLEURAL LOW-MOLECULAR-WEIGHT UROKINASE OR TISSUE PLASMINOGEN ACTIVATOR VERSUS SINGLE-CHAIN UROKINASE IN TETRACYCLINE-INDUCED PLEURAL LOCULATION IN RABBITS

T. Allen, A. Mazar, D. Cines, 2007, Experimental lung research.

Structural and functional analysis of caspase active sites.

A. Spada, K. Tomaselli, Joe C. Wu, 2003, Biochemistry.

Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.

M. Grütter, H. Blanchard, J. Wu, 2000, Journal of molecular biology.

Caspase‐8 Variant G Regulates Rheumatoid Arthritis Fibroblast‐Like Synoviocyte Aggressive Behavior

J. M. Sauder, Wei Wang, Rizi Ai, 2021, ACR open rheumatology.

Computational design of highly signaling active membrane receptors through de novo solvent-mediated allosteric networks

B. Chau, M. Rutter, P. Barth, 2021, bioRxiv.

Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.

N. Chen, J. Díaz, A. Schmitz, 2002, Bioorganic & medicinal chemistry letters.

Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimization.

J. Díaz, L. Fritz, K. Tomaselli, 2002, Bioorganic & medicinal chemistry letters.